Page 61 - Škrgat, Sabina, ed. 2022. Severe Asthma - Basic and Clinical Views. Koper: University of Primorska Press. Severe Asthma Forum, 1
P. 61
Gibeon D, Heaney LG, Brightling CE, cult-to-treat asthma. Eur Respir J. 2003 61
et al. Dedicated severe asthma services Sep;22(3):478-83.
improve health-care use and quality of 39. Grammatopoulou EP, Skordilis EK, the multi-disciplinary team approach to specialist adult difficult asthma care
life. Chest. 2015 Oct;148(4):870-6. Georgoudis G, et al. Hyperventilation
in asthma: a validation study of the Ni-
31. Denton E, Lee J, Tay T, et al. System- jmegen Questionnaire--NQ. J Asthma.
atic Assessment for Difficult and Se- 2014 Oct;51(8):839–46.
vere Asthma Improves Outcomes and 40. Bjelland I, Dahl AA, Haug TT, et al.
Halves Oral Corticosteroid Burden In- The validity of the Hospital Anxiety
dependent of Monoclonal Biologic Use. and Depression Scale: An updated lit-
J Allergy Clin Immunol Pract. 2020 erature review. J Psychosom Res. 2002
May;8(5):1616-24. Feb;52(2):69–77.
41. Johns MW. Reliability and factor anal-
32. Ryan D, Murphy A, Ställberg B, et ysis of the Epworth Sleepiness Scale.
al. ‘SIMPLES’: a structured prima- Sleep. 1992 Aug;15(4):376-81.
ry care approach to adults with diffi- 42. Hopkins C, Gillett S, Slack R, et al.
cult asthma. Prim Care Respir J. 2013 Psychometric validity of the 22-item Si-
Sep;22(3):365-73. nonasal Outcome Test. Clin Otolaryn-
gol. 2009 Oct;34(5):447-54.
33. Maltby S, Gibson PG, Reddel HK, et 43. Radhakrishna N, Tay TR, Hore-Lacy
al. Severe Asthma Toolkit: an online re- F, et al. Validated questionnaires height-
source for multidisciplinary health pro- en detection of difficult asthma comor-
fessionals-needs assessment, develop- bidities. J Asthma. 2017 Apr;54(3):294-
ment process and user analytics with 9.
survey feedback. BMJ Open. 2020 Mar 44. Melani AS, Bonavia M, Cilenti V, et
24;10(3):e032877. doi: 10.1136/bmjop- al. Inhaler mishandling remains com-
en-2019-032877. mon in real life and is associated with
reduced disease control. Respir Med.
34. Denton E, Hore-Lacy F, Radhakr- 2011 Jun;105(6):930–8.
ishna N, et al. Severe Asthma Glob- 45. Levy ML, Hardwell A, McKnight E,
al Evaluation (SAGE): An Electron- et al. Asthma patients’ inability to use
ic Platform for Severe Asthma. J Al- a pressurised metered-dose inhaler
lergy Clin Immunol Pract. 2019 May- (pMDI) correctly correlates with poor
Jun;7(5):1440-9. asthma control as defined by the global
initiative for asthma (GINA) strategy: a
35. Majellano EC, Clark VL, Winter NA, retrospective analysis. Prim Care Respir
et al. Approaches to the assessment of J. 2013 Dec;22(4):406-11.
severe asthma: barriers and strategies. J 46. Westerik JA, Carter V, Chrystyn H, et
Asthma Allergy. 2019 Aug;12:235-51. al. Characteristics of patients making
serious inhaler errors with a dry powder
36. Fuhlbrigge A, Marvel J, Electricwala inhaler and association with asthma-re-
B, et al. Physician-Patient Concordance lated events in a primary care setting. J
in the Assessment of Asthma Control. Asthma. 2016;53(3):321-9.
J Allergy Clin Immunol Pract. 2021 47. Price DB, Román-Rodríguez M, Mc-
Aug;9(8):3080-8.e1. Queen RB, et al. Inhaler Errors in the
CRITIKAL Study: Type, Frequen-
37. Radhakrishna N, Tay TR, Hore-La- cy, and Association with Asthma Out-
cy F, et al. Profile of difficult to treat
asthma patients referred for system-
atic assessment. Respir Med. 2016
Aug;117:166-73.

38. Robinson DS, Campbell DA, Durham
SR, et al. Systematic assessment of diffi-
   56   57   58   59   60   61   62   63   64   65   66